Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI
Refereed Congress / Symposium Publications in Proceedings

Pooled CRISPR Screening Identifies AP-1 Transcription Factor as a Druggable Driver of Osimertinib Resistance in Non-Small Cell Lung Cancer

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 10 - 13 June 2024, vol.18, pp.224 Sustainable Development

Genome-Wide CRISPR Screens: Unveiling BUB1 Kinase as a Druggable Vulnerability in Malignant Pleural Mesothelioma

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 10 - 13 June 2024, vol.18, pp.183-184

Genome-wide CRISPR Screening Identifies RUVBL1/2 Complex as a Druggable Vulnerability in Bladder Cancer

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 10 - 13 June 2024, vol.18, pp.180-181

Escape from TGF-β-induced Senescence Promotes Aggressive Cancer Hallmarks in Epithelial Hepatocellular Carcinoma Cells

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Netherlands, 10 - 13 June 2024, vol.18, pp.347-348 Sustainable Development

The Molecular Role of RUVBL1 Gene on Cancer Cell Phenotypes in Malignant Pleural Mesothelioma

The International Biochemistry Congress & 33rd National Biochemistry Congress, İzmir, Turkey, 26 - 30 October 2022 Sustainable Development

ATG9A Gene is Required for the Survival of Malignant Pleural Mesthelioma Cells

The International Biochemistry Congress & 33rd National Biochemistry Congress, İzmir, Turkey, 26 - 30 October 2022, pp.1-5 Sustainable Development

AXL is essential for survival of mesenchymal-like HCC cells

8th International Congress of the Molecular Biology Association of Turkey, İstanbul, Turkey, 9 - 12 June 2022

The Role of Autophagy on Differentiation of Corneal Endothelial Cells from hiPSCs

8th International Congress of the Molecular Biology Association of Turkey, İstanbul, Turkey, 9 - 12 June 2022

Targeted delivery of CRISPR/Cas9 plasmid system for cancer immunotherapy approaches

13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Amsterdam, Netherlands, 28 - 31 March 2022

Generation of R132H point mutation by CRISPR/Cas9 method in colorectal cancer cell line

3. Uluslararası Kanser ve İyon Kanalları Kongresi (CANCERION-2021), 16 September 2021 Sustainable Development

Generation of R132H point mutation by CRISPR/Cas9 method in colon cancer cell line

3. Uluslararası Kanser ve İyon Kanalları Kongresi, İstanbul, Turkey, 16 - 18 September 2021 Sustainable Development

Revealing the Role of Retinoids On the Phenotypic and Epigenetic Landscape of Bladder Cancer Cells

6. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi, Ankara, Turkey, 10 - 11 April 2021 Sustainable Development

Gen Düzeltme ve CRISPR

Türk Toraks Derneği 23. Yıllık Kongresi, Turkey, 15 - 18 October 2020

Genç Araştırmacılar İçin Fırsatlar

BioTürkiye - Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 5 - 07 March 2020

CRISPR-Cas9 Genom Düzenleme

22. EGE Onkoloji Günleri-Onkolojide Yeni Tedavi Arayışları Sempozyumu, Turkey, 26 - 28 February 2020

Genome-wide CRISPR-Cas9 screening for the identification of cancer essential genes in malignant pleural mesothelioma

27th Balkan Clinical Laboratory Federation Congress and 30th National Biochemistry Congress, Turkey, 27 - 31 October 2019, vol.44 Sustainable Development

Kanser Esansiyel Genlerin Tüm Genom CRISPR-Cas9 Taramalarla Araştırılması

İmmünolojide Moleküller Sempozyumu, Turkey, 18 - 21 October 2018 Sustainable Development

Systematic Comparison of Constitutive Promoters in Chinese Hamster Ovary Cells

6th International Congress of the Molecular Biology Association of Turkey, 5 - 08 September 2018

The Role of Malt1 Paracaspase in Hepatocellular Carcinoma

6th International Congress of the Molecular Biology Association of Turkey, 5 - 08 September 2018

AXL as a Potential Target in Liver Cancer

6th International Congress of the Molecular Biology Association of Turkey, 5 - 08 September 2018 Sustainable Development

THE NEW FRONTIER OF GENOME ENGINEERING: THE CRISPR/CAS9 SYSTEM

The Second International Biomedical Engineering Congress, 24 - 27 May 2018

Genom Mühendisliği ve CRISPR-Cas Devrimi

14. Ulusal Histoloji ve Embriyoloji Kongresi, Turkey, 10 - 13 May 2018

Biyobelirteçler ve CRISPR

II. Türkiye in vitro Diyagnostik (IVD) Sempozyumu, Turkey, 10 - 12 May 2017

In Vitro and In Vivo Characterization Of Cell Survival Genes Using Destabilized Cas9

1st International Cell Death Research Congress, İzmir, Turkey, 4 - 07 May 2016

Myc drives Pten/ p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression via Phlpp2

106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Pennsylvania, United States Of America, 18 - 22 April 2015, vol.75 identifier

Does Akt Inactivation promote metastasis of PTEN mutant cancer

Biology of Cancer: Microenvironment, Metastasis & Therapeutics, 12 - 16 May 2015 Sustainable Development

Substrate specificity of receptor tyrosine kinases is critical for selective signaling and addiction

Protein Phosphorylation, Cellular Plasticity and Signaling Rewiring, FASEB Meeting, 20 - 25 July 2014

TGF-BETA SIGNALING IS FUNCTIONAL, BUT ITS SENESCENCE RESPONSE IS DEFECTIVE IN POORLY DIFFERENTIATED HEPATOCELLULAR CARCINOMA CELL LINES

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 30 October - 03 November 2009, vol.50 identifier

The Effects of Telomerase Inhibitor GRN163L on Different Cell Lines

2nd FEBS Advanced Lecture Course on Matrix Pathobiology, Patras, Greece, 11 - 16 July 2009

Downregulation and the anti growth effect of Zeb2 in hepatocellular carcinoma

Joint 4th EORTC Annual Meeting & 1st International Multidisciplinary Cancer Research Congress, 21 - 24 May 2009

TGF beta induces senescence in epithelial like hepatocellular carcinoma cells

Joint 4th EORTC Annual Meeting & 1st International Multidisciplinary Cancer Research Congress, 21 - 24 May 2009

Molecular Mechanisms of TGF beta induced senescence in hepatocellular carcinoma

20. ULUSAL BİYOKİMYA KONGRESİ, Turkey, 29 October - 01 November 2008

Induction of replicative senescence in hepatocellular carcinoma cells

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.224-225 identifier

Role of TGF-beta signaling in hepatocellular senescence

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.225 identifier

Characterization of TGF beta induced Early Senescence in Hepatocellular Carcinoma Cell Lines

ICGEB Workshop Emerging Topics in Human Functional Genomics and Proteomics, 26 - 31 March 2006
Books & Book Chapters

Challenges in First-Line Osimertinib Therapy in EGFR-Mutant Non-small Cell Lung Cancer: Acquired Resistance Is the Issue

in: Lung Cancer Diagnosis and Treatment: An Interdisciplinary Approach, Rezaei Nima, Editor, Springer, Londrina, pp.217-247, 2024 Sustainable Development

CRISPR/Cas9 Therapy in Cancer Treatment

in: Innovative Approaches in Cancer Diagnosis and Treatment, YAR SAĞLAM ATİYE SEDA, Editor, Türkiye Klinikleri Medical Biology - Special Topics, pp.44-52, 2024

RUVBL1/2 Complex in Cancer: Emerging Mechanisms and Therapeutic Opportunities

in: Interdisciplinary Cancer Research, Rezaei Nima, Editor, Springer, Cham, Londrina, pp.1-24, 2024

Structure and Function of the H19 Long Non-coding RNA in Cancer

in: Interdisciplinary Cancer Research, Nima Rezaei, Editor, Springer, London/Berlin , London, pp.1-27, 2023

CRISPR/Cas9 Gene Editing in Mammalian Cells Using LentiCRISPRv2/LentiGuide-Puro Vectors

in: CRISPR-Cas Methods, M. Tofazzal Islam,Kutubuddin Ali Molla, Editor, Springer, London/Berlin , New York, pp.281-299, 2021

Inducible CRISPR-based Genome Editing for the Characterization of Cancer Genes

in: Genome Editing and Engineering: From TALENs, ZFNs and CRISPRs to Molecular Surgery, Krishnarao Appasani, Editor, Cambridge University Press, Cambridge (MA), USA , London, pp.337-357, 2018
Metrics

Publication

123

Citation (WoS)

2182

H-Index (WoS)

16

Citation (Scopus)

2789

H-Index (Scopus)

17

H-Index (Scholar)

18

Project

27

Intellectual Property

1

Thesis Advisory

19

Open Access

23
UN Sustainable Development Goals